Indeed, a recent study showed that treatment with a TIE1 function-blocking antibody in a presurgical neoadjuvant setting suppressed distant organ metastasis [50], suggesting TIE1 as a promising therapeutic target in cancer treatment. This evidence concerns the gene TIE1 and cancer.